FDA Announces Final Guidance for Blood Glucose Monitoring Test Systems

Summary

The Food and Drug Administration has released a final guidance document outlining studies and information that FDA recommends for blood glucose monitoring systems used in prescription point-of-care settings, in preparation for submitting premarket notifications for these systems.